<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T17:15:43Z</responseDate>
  <request identifier="oai:figshare.com:article/32628225" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/32628225</identifier>
        <datestamp>2026-10-01T17:41:29Z</datestamp>
        <setSpec>portal_1172</setSpec>
        <setSpec>item_type_8</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>A bioactive peptide from the skin secretion of the Red-eyed Leaf Frog, Agalychnis callidryas</dc:title>
          <dc:creator>Yan Zhang (8098)</dc:creator>
          <dc:subject>PUREID: 184347600</dc:subject>
          <dc:description>Natural products, as rich and varied resources for the discovery of novel drugs, have been essential for human healthcare systems throughout history. A variety of bioactive components with unique structures and functions isolated from the skin secretion of amphibians, especially peptides, have enormous potential for medical purposes. &lt;br&gt;&lt;br&gt;Here, a peptide from the phylloseptin family was identified from the Red-eyed Leaf Frog, Agalychnis callidryas, by molecular cloning. This peptide was named as QUB-1541 based on its molecule weight. Then the mature peptide was successfully synthesised by Tribute® 2-channel peptide synthesiser. Reversed-phase high- performance liquid chromatography (RP-HPLC) was used for purification and matrix-assisted laser desorption ionisation time-of-flight (MALDI-TOF) MS was used to confirm its molecular mass. QUB-1541 has better inhibitory activity against gram-positive bacteria than gram-negative bacteria. The MIC for S. aureus is 8 μM while for E. coli is 512 μM. Also, QUB-1541 inhibits the growth of yeast, C. albicans and the MIC is 128 μM. The results of MBC show that QUB-1541 has no bactericidal effect on E. coli and C. albicans at the highest concentration. However, QUB-1541 kills S. aureus at a lower level of 16 μM, while the haemolysis is weak. QUB-1541 was only effective against cancer cells, PC-3, U251MG and H157 at the highest concentration of 10-4 M. Thus, QUB-1541 has the value of subsequent research.&lt;br&gt;&lt;br&gt;&lt;i&gt;Thesis embargoed until 31st October 2024 &lt;/i&gt;&lt;br&gt;</dc:description>
          <dc:date>2026-10-01T17:41:29Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Thesis</dc:type>
          <dc:identifier>10.17034/32628225.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/thesis/A_bioactive_peptide_from_the_skin_secretion_of_the_Red-eyed_Leaf_Frog_Agalychnis_callidryas/32628225</dc:relation>
          <dc:rights>All Rights Reserved</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
